FNY Managed Accounts’s Raptor Pharmaceutical RPTP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-12,423
Closed -$111K – 430
2016
Q3
$111K Buy
+12,423
New +$88.3K 0.09% 131

FNY Managed Accounts's RPTP Position: Q4 2016 in Review

FNY Managed Accounts sold out of Raptor Pharmaceutical (RPTP) in Q4 2016, closing a stake of 12,423 shares — an estimated $111K sold.

FNY Managed Accounts first reported a position in RPTP in Q3 2016 and held it in 1 quarter. The position peaked at $111K in Q3 2016. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.

  • FNY Managed Accounts reported no remaining Raptor Pharmaceutical position as of Q4 2016 after selling out during the quarter.
  • FNY Managed Accounts sold 12,423 Raptor Pharmaceutical shares in Q4 2016, an estimated $111K.
  • FNY Managed Accounts first reported a position in Raptor Pharmaceutical in Q3 2016 and held it in 1 quarter.
  • FNY Managed Accounts's Raptor Pharmaceutical position peaked at $111K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Raptor Pharmaceutical as of Q4 2016.

Based on FNY Managed Accounts's 13F filing for Q4 2016, filed 8 Feb 2017.